Impact of climate change on aeroallergens

INSTRUCTIONS Credit can now be obtained, free for a limited time, by reading the review article in this issue and completing all activity components. Please note the instructions listed below: • Review the target audience, learning objectives and all disclosures. • Complete the pre-test online at http://www.annallergy.org (click on the CME heading). • Follow the online instructions to read the full version of the article; reflect on all content as to how it may be applicable to your practice. • Complete the post-test/evaluation and claim credit earned; at this time, you will have earned up to 1.0 AMA PRA Category 1 Credit™. Please note that the minimum passing score on the post-test is 70%. Release Date: May 1, 2012. Expiration Date: April 30, 2014 Estimated Time to Complete: 60 minutes Target Audience: Physicians involved in providing patient care in the field of allergy/asthma/immunology Learning Objectives: At the conclusion of this activity, participants should be able to: • Describe the techniques involved in the assessment of global climate change. • Summarize the importance of changes in vegetation phenology on assessing climate change. • Discuss the impact of changes in ambient carbon dioxide and temperature on aeroallergenic plants and their production of pollen. • Discuss the impact of ambient carbon dioxide changes on plant-fungi interactions and airborne fungal allergen burden. Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Planning Committee Members: Richard W. Weber, MD (Author) Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief) Disclosure of Relevant Financial Relationships: R.W. Weber is on the speakers' bureau for AstraZeneca and Genentech and has received research grants from Merck, Novartis and Pfizer. G.D. Marshall has nothing to disclose. No unapproved/investigative use of a product/device is discussed. Recognition of Commercial Support: This activity has not received external commercial support. Copyright Statement: @ 2012-2014 ACAAI. All rights reserved. CME Inquiries: Contact the American College of Allergy, Asthma & Immunology at [email protected] or 847-427-1200. INSTRUCTIONS Credit can now be obtained, free for a limited time, by reading the review article in this issue and completing all activity components. Please note the instructions listed below: • Review the target audience, learning objectives and all disclosures. • Complete the pre-test online at http://www.annallergy.org (click on the CME heading). • Follow the online instructions to read the full version of the article; reflect on all content as to how it may be applicable to your practice. • Complete the post-test/evaluation and claim credit earned; at this time, you will have earned up to 1.0 AMA PRA Category 1 Credit™. Please note that the minimum passing score on the post-test is 70%. Release Date: May 1, 2012. Expiration Date: April 30, 2014 Estimated Time to Complete: 60 minutes Target Audience: Physicians involved in providing patient care in the field of allergy/asthma/immunology Learning Objectives: At the conclusion of this activity, participants should be able to: • Describe the techniques involved in the assessment of global climate change. • Summarize the importance of changes in vegetation phenology on assessing climate change. • Discuss the impact of changes in ambient carbon dioxide and temperature on aeroallergenic plants and their production of pollen. • Discuss the impact of ambient carbon dioxide changes on plant-fungi interactions and airborne fungal allergen burden. Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Planning Committee Members: Richard W. Weber, MD (Author) Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief) Disclosure of Relevant Financial Relationships: R.W. Weber is on the speakers' bureau for AstraZeneca and Genentech and has received research grants from Merck, Novartis and Pfizer. G.D. Marshall has nothing to disclose. No unapproved/investigative use of a product/device is discussed. Recognition of Commercial Support: This activity has not received external commercial support. Copyright Statement: @ 2012-2014 ACAAI. All rights reserved. CME Inquiries: Contact the American College of Allergy, Asthma & Immunology at [email protected] or 847-427-1200.